Advertisement

A Review of Quality-of-Life Assessment Measures in Schizophrenia: Limitations and Future Developments

  • María Teresa Bobes-Bascarán
  • María Paz García-Portilla
  • Pilar A. Sáiz Martínez
  • Leticia García-Alvarez
  • Isabel Menéndez-Miranda
  • Susana Al-Halabí
  • María Teresa Bascarán
  • Julio BobesEmail author
Chapter
  • 652 Downloads

Abstract

The assessment of quality of life (QoL) in patients with schizophrenia is an area of growing concern since it is considered an essential distal outcome for clinical trials and patient management (Auquier et al. 2003; Awad and Voruganti 2012) according to the patient-reported outcome (PRO) movement in medicine (see Fig. 5.1). Its evaluation is founded on the notion that every patient has a right to self-determination in health-care decisions and his/her subjective perspective should be considered in both diagnosis and care planning processes (Awad and Voruganti 2012; Badia et al. 1999; Bilker et al. 2003).

Keywords

Life Satisfaction Differential Item Functioning Life Domain Computerize Adaptive Testing Care Planning Process 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Auquier P, Simeoni MC, Sapin C, Reine G, Aghababian V, Cramer J, et al. Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: the S-QoL. Schizophr Res. 2003;63(1–2):137–49.CrossRefPubMedGoogle Scholar
  2. Awad AG, Voruganti LN. Measuring quality of life in patients with schizophrenia: an update. Pharmacoeconomics. 2012;30(3):183–95.CrossRefPubMedGoogle Scholar
  3. Badia X, Roset M, Montserrat S, Herdman M, Segura A. The Spanish version of EuroQol: a description and its applications. European quality of life scale. Med Clin. 1999;112 Suppl 1:79–85.Google Scholar
  4. Bilker WB, Brensinger C, Kurtz MM, Kohler C, Gur RC, Siegel SJ, et al. Development of an abbreviated schizophrenia quality of life scale using a new method. Neuropsychopharmacology. 2003;28(4):773–7.CrossRefPubMedGoogle Scholar
  5. Bobes J. Current status of quality of life assessment in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci. 2001;251 Suppl 2:II38–42.CrossRefPubMedGoogle Scholar
  6. Bobes J, Garcia-Portilla P, Saiz PA, Bascaran T, Bousono M. Quality of life measures in schizophrenia. Eur Psychiatry. 2005;20 Suppl 3:S313–7.CrossRefPubMedGoogle Scholar
  7. Bobes J, Garcia-Portilla MP, Bascaran MT, Saiz PA, Bousono M. Quality of life in schizophrenic patients. Dialogues Clin Neurosci. 2007;9(2):215–26.PubMedPubMedCentralGoogle Scholar
  8. Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53–72.CrossRefPubMedGoogle Scholar
  9. Browne S, Roe M, Lane A, Gervin M, Morris M, Kinsella A, et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand. 1996;94(2):118–24.CrossRefPubMedGoogle Scholar
  10. Bullinger M, Quitmann J. Quality of life as patient-reported outcomes: principles of assessment. Dialogues Clin Neurosci. 2014;16(2):137–45.PubMedPubMedCentralGoogle Scholar
  11. Calman KC. Quality of life in cancer patients – an hypothesis. J Med Ethics. 1984;10(3):124–7.CrossRefPubMedPubMedCentralGoogle Scholar
  12. Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63(11):1179–94.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993;29(2):321–6.PubMedGoogle Scholar
  14. Evenson RC, Vieweg BW. Using a quality of life measure to investigate outcome in outpatient treatment of severely impaired psychiatric clients. Compr Psychiatry. 1998;39(2):57–62.CrossRefPubMedGoogle Scholar
  15. Fervaha G, Remington G. Validation of an abbreviated quality of life scale for schizophrenia. Eur Neuropsychopharmacol. 2013;23(9):1072–7.CrossRefPubMedGoogle Scholar
  16. Fervaha G, Foussias G, Siddiqui I, Agid O, Remington G. Abbreviated quality of life scales for schizophrenia: comparison and utility of two brief community functioning measures. Schizophr Res. 2014;154(1–3):89–92.CrossRefPubMedGoogle Scholar
  17. Gaite L, Vazquez-Barquero JL, Arrizabalaga Arrizabalaga A, Schene AH, Welcher B, Thornicroft G, et al. Quality of life in schizophrenia: development, reliability and internal consistency of the Lancashire Quality of Life Profile – European version. EPSILON study 8. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs. Br J Psychiatry Suppl. 2000;39:s49–54.CrossRefPubMedGoogle Scholar
  18. Garcia-Portilla MP, Garcia-Alvarez L, Menendez-Miranda I, Al-Halabi S, Bobes-Bascaran MT, Saiz-Martinez PA, et al. Escalas de funcionalidad, discapacidad y calidad de vida en esquizofrenia. Drugs in context. Barcelona: J&C Ediciones Medicas, SL; 2015.Google Scholar
  19. Gomez JC, Sacristan JA, Hernandez J, Breier A, Ruiz Carrasco P, Anton Saiz C, et al. The safety of olanzapine compared with other antipsychotic drugs: results of an observational prospective study in patients with schizophrenia (EFESO study). Pharmacoepidemiologic study of olanzapine in schizophrenia. J Clin Psychiatry. 2000;61(5):335–43.CrossRefPubMedGoogle Scholar
  20. Harvey PD. Assessment of everyday functioning in schizophrenia: implications for treatments aimed at negative symptoms. Schizophr Res. 2013;150(2–3):353–5.CrossRefPubMedGoogle Scholar
  21. Hayhurst KP, Massie JA, Dunn G, Lewis SW, Drake RJ. Validity of subjective versus objective quality of life assessment in people with schizophrenia. BMC Psychiatry. 2014;14:365.CrossRefPubMedPubMedCentralGoogle Scholar
  22. Heinrichs DW, Hanlon TE, Carpenter Jr WT. The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull. 1984;10(3):388–98.CrossRefPubMedGoogle Scholar
  23. Insel TR. Rethinking schizophrenia. Nature. 2010;468:187–93.CrossRefPubMedGoogle Scholar
  24. Karow A, Wittmann L, Schottle D, Schafer I, Lambert M. The assessment of quality of life in clinical practice in patients with schizophrenia. Dialogues Clin Neurosci. 2014;16(2):185–95.PubMedPubMedCentralGoogle Scholar
  25. Kind P. The EuroQoL instrument: an index of HRQOL. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia: Lippincott-Raven; 1996. p. 191–201.Google Scholar
  26. Lehman AF. The effects of psychiatric symptoms on quality of life assessments among the chronic mentally ill. Eval Program Plann. 1983;6(2):143–51.CrossRefPubMedGoogle Scholar
  27. Lehman AF. A quality of life interview for the chronically mentally ill. Eval Program Plann. 1988;11:51–62.CrossRefGoogle Scholar
  28. Lehman AF, Postrado LT, Rachuba LT. Convergent validation of quality of life assessments for persons with severe mental illnesses. Qual Life Res. 1993;2(5):327–33.CrossRefPubMedGoogle Scholar
  29. Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, Gilmore J. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry. 2001;50:884–97.CrossRefPubMedGoogle Scholar
  30. Naber D. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol. 1995;10 Suppl 3:133–8.PubMedGoogle Scholar
  31. Naber D, Moritz S, Lambert M, Pajonk FG, Holzbach R, Mass R, et al. Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs. Schizophr Res. 2001;50(1–2):79–88.CrossRefPubMedGoogle Scholar
  32. Oliver JP, Huxley PJ, Priebe S, Kaiser W. Measuring the quality of life of severely mentally ill people using the Lancashire quality of life profile. Soc Psychiatry Psychiatr Epidemiol. 1997;32(2):76–83.CrossRefPubMedGoogle Scholar
  33. Orsel S, Akdemir A, Dag I. The sensitivity of quality-of-life scale WHOQOL-100 to psychopathological measures in schizophrenia. Compr Psychiatry. 2004;45(1):57–61.CrossRefPubMedGoogle Scholar
  34. Park IJ, Jung DC, Hwang SS, Jung HY, Yoon JS, Kim CE, et al. Refinement of the SWN-20 based on the Rasch rating model. Compr Psychiatry. 2015;60:134–41.CrossRefPubMedGoogle Scholar
  35. Priebe S, Huxley P, Knight S, Evans S. Application and results of the Manchester Short Assessment of Quality of Life (MANSA). Int J Soc Psychiatry. 1999;45(1):7–12.CrossRefPubMedGoogle Scholar
  36. Prieto L, Sacristan JA, Hormaechea JA, Casado A, Badia X, Gomez JC. Psychometric validation of a generic health-related quality of life measure (EQ-5D) in a sample of schizophrenic patients. Curr Med Res Opin. 2004;20(6):827–35.CrossRefPubMedGoogle Scholar
  37. Pukrop R, Schlaak V, Moller-Leimkuhler AM, Albus M, Czernik A, Klosterkotter J, et al. Reliability and validity of quality of life assessed by the short-form 36 and the modular system for quality of life in patients with schizophrenia and patients with depression. Psychiatry Res. 2003;119(1–2):63–79.CrossRefPubMedGoogle Scholar
  38. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–43.CrossRefPubMedGoogle Scholar
  39. Revicki DA, Kleinman L, Cella D. A history of health-related quality of life outcomes in psychiatry. Dialogues Clin Neurosci. 2014;16(2):127–35.PubMedPubMedCentralGoogle Scholar
  40. Ritsner M, Kurs R, Gibel A, Ratner Y, Endicott J. Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients. Qual Life Res. 2005;14(7):1693–703.CrossRefPubMedGoogle Scholar
  41. Schmidt P, Clouth J, Haggenmuller L, Naber D, Reitberger U. Constructing an Index for the Subjective Well-being Under Neuroleptics scale (SWN), short form: applying structural equation modeling for testing reliability and validity of the index. Qual Life Res. 2006;15(7):1191–202.CrossRefPubMedGoogle Scholar
  42. Skantze K, Malm U, Dencker SJ, May PR, Corrigan P. Comparison of quality of life with standard of living in schizophrenic out-patients. Br J Psychiatry. 1992;161:797–801.CrossRefPubMedGoogle Scholar
  43. Voruganti LN, Awad AG. Personal evaluation of transitions in treatment (PETiT): a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia. Schizophr Res. 2002;56(1–2):37–46.CrossRefPubMedGoogle Scholar
  44. Vothknecht S, Meijer C, Zwinderman A, Kikkert M, Dekker J, van Beveren N, et al. Psychometric evaluation of the Subjective Well-being Under Neuroleptic Treatment Scale (SWN) in patients with schizophrenia, their relatives and controls. Psychiatry Res. 2013;206(1):62–7.CrossRefPubMedGoogle Scholar
  45. Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.CrossRefPubMedGoogle Scholar
  46. Ware Jr J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.CrossRefPubMedGoogle Scholar
  47. Ware JE, Kosinski M, Turner-Bowker DM. User’s manual for the SF-12v2 health survey with a supplement documenting SF-12 health survey. Lincoln: Quality Metric Incorporated; 2002.Google Scholar
  48. WHO. Measuring quality of life. The development of the World Health Organization Quality of Life Instrument (WHOQOL-100). Genève: WHO; 1993.Google Scholar
  49. WHO. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998;28:551–8.CrossRefGoogle Scholar
  50. Wilkinson G, Hesdon B, Wild D, Cookson R, Farina C, Sharma V, et al. Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry. 2000;177:42–6.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • María Teresa Bobes-Bascarán
    • 1
  • María Paz García-Portilla
    • 2
    • 3
  • Pilar A. Sáiz Martínez
    • 2
    • 3
  • Leticia García-Alvarez
    • 2
    • 3
  • Isabel Menéndez-Miranda
    • 4
  • Susana Al-Halabí
    • 2
  • María Teresa Bascarán
    • 2
  • Julio Bobes
    • 2
    • 3
    Email author
  1. 1.Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAMValenciaSpain
  2. 2.Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAMOviedoSpain
  3. 3.Department of PsychiatryUniversity of OviedoOviedoSpain
  4. 4.Mental Health Services of AsturiasOviedoSpain

Personalised recommendations